SCND: Scientific Industries, Inc. Stock

SIC 3826 – Laboratory Analytical Instruments

Valuation
Market Cap ($M) 15.13
Enterprise Value ($M) 14.56
Book Value ($M) 10.93
Book Value / Share 1.04
Price / Book 1.38
NCAV ($M) 7.28
NCAV / Share 0.69
Price / NCAV 2.08

Profitability (mra)
Return on Invested Capital (ROIC) -0.56
Return on Assets (ROA) -0.52
Return on Equity (ROE) -0.68

Liquidity (mrq)
Quick Ratio 3.02
Current Ratio 5.99

Balance Sheet (mrq) ($M)
Current Assets 9.65
Assets 13.31
Liabilities 2.37
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-14 13G/A Lytton Laurence W 9.99 -1.47
11-13 13D/A Bleichroeder LP 20.95 0.00
03-21 13G/A North Run Capital, Lp 9.99 -26.29
02-14 13G/A Satterfield Thomas A Jr 9.02 58.41
12-29 13D Veradace Capital Management LLC 13.56

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SE
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION
2024-07-18 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PUR
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTIO
2024-03-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13

(click for more detail)

Similar Companies
QURT – Quarta-Rad, Inc. RLBY – Reliability Incorporated
RSCF – Reflect Scientific, Inc. SDMHF – Sartorius Stedim Biotech S.A.
SFPI – Santa Fe Petroleum, Inc.


Financial data and stock pages provided by
Fintel.io



This entry was posted in . Bookmark the permalink.